Principal Financial Group Inc Curis Inc Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.74 - $15.01 $233 - $4,728	315 Added 3.06%	10,597 $7,000
Q2 2022 Aug 10, 2022	SELL	$0.71 - $2.43 $72,636 - $248,601	-102,305 Reduced 90.87%	10,282 $10,000
Q1 2022 May 09, 2022	SELL	$2.31 - $5.13 $101,709 - $225,873	-44,030 Reduced 28.11%	112,587 $268,000
Q4 2021 Feb 09, 2022	SELL	$4.45 - $8.09 $62,402 - $113,446	-14,023 Reduced 8.22%	156,617 $745,000
Q3 2021 Nov 09, 2021	SELL	$6.94 - $8.85 $3,754 - $4,787	-541 Reduced 0.32%	170,640 $1.34 Million
Q2 2021 Aug 10, 2021	BUY	$7.45 - $16.27 $1.28 Million - $2.79 Million	171,181 New	171,181 $1.38 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.